Gulf Pharmaceutical Industries (Julphar) operates as a publicly listed joint-stock corporation traded on the Abu Dhabi Securities Exchange, meaning its ownership is distributed among institutional investment funds, financial institutions, and individual public shareholders. A significant strategic ownership interest is held by government-backed entities and prominent regional investment groups from the United Arab Emirates, including entities linked to the Government of Ras Al Khaimah. This robust institutional backing provides the enterprise with strong financial stability, capital support, and strategic direction to execute its long-term regional and international pharmaceutical expansion objectives.